Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet’s disease
Abstract Background Tumor necrosis factor (TNF) inhibitors (TNF-i) are effective in the treatment of entero-Behcet’s disease (BD). However, there is no objective tool for assessment of disease activity in entero-BD; therefore, it is not easy to evaluate treatment effectiveness in the clinical settin...
Main Authors: | Ippei Miyagawa, Kazuhisa Nakano, Shigeru Iwata, Shingo Nakayamada, Kazuyoshi Saito, Kentaro Hanami, Shunsuke Fukuyo, Satoshi Kubo, Akio Kawabe, Yusuke Miyazaki, Yoshiya Tanaka |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13075-019-1933-8 |
Similar Items
-
Ocular Behçet Disease—Clinical Manifestations, Treatments and Outcomes According to Age at Disease Onset
by: Michael Ostrovsky, et al.
Published: (2023-02-01) -
Ocular Manifestations of Behçet’s Disease: An Update on Diagnostic Challenges and Disease Management
by: Hanna Zając, et al.
Published: (2021-11-01) -
Behçet’s disease diagnosed by pregnancy-exacerbated genital ulcers
by: Nobuyuki Kikuchi, et al.
Published: (2018-02-01) -
Superior vena cava syndrome caused by behcet’s disease
by: R Kilicarslan, et al.
Published: (2013-07-01) -
Interleukin-17 in Behçet′s disease: relation with clinical picture and disease activity
by: Dina S Al-Zifzaf, et al.
Published: (2015-01-01)